Advertisement

Topics

Murex Biotech Limited Company Profile

02:47 EDT 26th August 2016 | BioPortfolio

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex, we are dedicated to the development and manufacture of products for the:

  • detection
  • monitoring
  • screening of infectious diseases and other medical conditions.
Murex is based at Dartford, Kent, and its principle focus is a range of enzyme immunoassay products for use by blood transfusion services throughout the world to screen for infectious agents such as hepatitis and HIV. In addition, we have a growing biotechnology group who manufacture recombinant proteins and monoclonal antibodies for use in Abbott products.

Location

Central Road
Dartford
DA1 5LR
United Kingdom

Contact

Phone: 00 44 1322 277711


News Articles [1609 Associated News Articles listed on BioPortfolio]

TriNet Insights Presents: Navigating Uncertainties to Reach the Next Levels for Midsize Biotech Companies

SAN DIEGO, CA--(Marketwired - August 11, 2016) - WHO: Craig Shimasaki, Ph.D., MBA is president & CEO of Moleculera Labs, an autoimmune neurobiology company. He is a scientist and serial entrepren...

#jobs #lifescience R&D Engineer- Biotech

// MA-Framingham, R&D Engineer- Biotech The Company Our client, a leader in their industry, is seeking an experienced R&D Engineer- Biotech for its manufacturing facility located in Framingh...

#news #biotech Swiss biotech continues to do well

// Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased by 5.1% to CHF5,133m and 400 additional people found jobs in the sector. As usual, the...

#news #biotech Dermatology biotech Novan goes for $60M IPO

// Dermatology biotech Novan goes for $60M IPO badams Thu, 08/25/2016 – 08:37 from Biotech Stories http://ift.tt/2bqxcg2 Cet article #news #biotech Dermatology biotech Novan goes for $60M IPO es...

Bad News this Week for Biotech Deals? News from Biospace on Deals week of 3/7/2016

Bad News this Week for Biotech Deals?   Stephen J. Williams, Ph.D.; Curator   Last week in biotech ( 3/7-3/11/2016) had a plethora of disappointing stories related to biotech drug development an...

BRIEF-Otcpharm to liquidate DONELLE COMPANY LIMITED

* Decides to liquidate DONELLE COMPANY LIMITED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BB Biotech: Biotech-Investment mit Expertise - Die beste Alternative für Privatanleger?

Mehr als sechs Jahre dauerte die Rallye der US-Biotech-Aktien. Zwischen März 2009 und vergangenen Sommer konnte sich der Nasdaq Biotech Indexbeinahe versiebenfachen, ohne zwischendrin größere Korre...

"BB Biotech: Biotech-Investment mit Expertise – Die beste Alternative für Privatanleger?"

Mehr als sechs Jahre dauerte die Rallye der US-Biotech-Aktien. Zwischen März 2009 und vergangenen Sommer konnte sich der Nasdaq Biotech Indexbeinahe versiebenfachen, ohne zwischendrin größere Korre...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

1306: LIMITED RAPID RESPONSE SYSTEM (RRS) COULD REDUCE UNEXPECTED HOSPITAL MORTALITY IN JAPAN.

894: IMPLEMENTING PATIENT SAFETY GOAL BUNDLES IN NIGERIA: PRACTICE REVIEW IN A RESOURCE LIMITED SETTING.

Response to proposed research to reverse brain death: more than regulatory failure.

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration be...

Erratum: When biotech goes bad.

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Companies [870 Associated Companies listed on BioPortfolio]

Murex Biotech Limited

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

More Information about "Murex Biotech Limited" on BioPortfolio

We have published hundreds of Murex Biotech Limited news stories on BioPortfolio along with dozens of Murex Biotech Limited Clinical Trials and PubMed Articles about Murex Biotech Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Murex Biotech Limited Companies in our database. You can also find out about relevant Murex Biotech Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record